Blog
3 ETFs to Double Up On Right Now
The market continues to climb higher, but some ETFs have not been partaking in all the gains yet still look intriguing moving forward. Each of these ETFs provides a unique look at the stock market
Bargains or Busts? These 3 Dividend Stocks Pay More Than 4% and Are Trading Near Their 52-Week Lows
It's been a good year for the stock market as a whole, with the S&P 500 rising by 14% year to date (as of Sept. 22) and hitting new highs along the way. There have, however, also been no shortages
This Beaten-Down AI Stock Could Stage a Monster Comeback by 2028
ASML Holding (NASDAQ: ASML) is one of the most important players in the global semiconductor industry. The Dutch semiconductor equipment giant manufactures machines that play a critical role in
Should You Buy Ford While It's Below $13?
Ford (NYSE: F) has likely been on the radar of many investors lately as the company recently announced plans to launch an entirely new electric vehicle platform. Its aim is to boost profitability
This Company Has Bought $16 Billion of Its Own Stock -- Should You?
It's challenging to find diamonds in the rough in the markets, because investors are smart and investment knowledge is everywhere. But one such opportunity exists in the least likely place for
Did Pfizer Just Give Investors 7 Billion Reasons to Buy Its Stock?
In the pharmaceutical world, if you can't develop 'em, acquire 'em. That seems to be the philosophy behind Pfizer's (NYSE: PFE) latest big-ticket buy, specifically its purchase of clinical-stage
Why Iren Stock Surged Higher This Week
Iren Limited (NASDAQ: IREN) is catching the attention of Wall Street analysts. Several new notes came out this week supporting the buy case for Iren stock.
Demand for the services of the data center
Why Did Direct-to-Consumer Retailers Stumble?
In this podcast, Motley Fool contributors Travis Hoium, Lou Whiteman, and Rachel Warren discuss:
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When
Should You Buy Chainlink While It's Under $53?
Chainlink (CRYPTO: LINK), a blockchain focused on aggregating real-world data, was created in 2017. It launched its native Link token in an initial coin offering (ICO) that September, and it started
Is Micron Stock the Best Buy Now?
Micron Technology (NASDAQ: MU) has proved to be one of the biggest winners of the global artificial intelligence (AI) infrastructure buildout. While semiconductor companies like Nvidia and Broadcom
Rule Breaker Investing Mailbag: The House That Netflix Built
In this podcast, Motley Fool co-founder David Gardner talks about a listener who says he invests $100 for each of his daughters' birthdays, positioning them for success in their financial futures
Why Strategy Stock Was Sinking This Week
Across the past several trading sessions, a wise investment strategy would have been to avoid shares of Strategy Inc. (NASDAQ: MSTR). The institutional Bitcoin investor's stock was off by almost
Underappreciated Rule-Breaking Small-Cap Stocks
In this podcast, Motley Fool analyst Emily Flippen and contributors Jason Hall and Toby Bordelon dive into:
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast
Domino's Isn't Just Selling Pizza. It's Building a Global Platform
Domino's Pizza (NASDAQ: DPZ) may be best known for late-night delivery, but for investors it represents something bigger. One of the most durable growth stories in the restaurant industry. Over the
Why Firefly Aviation's Stock Was Nose-Diving This Week
Firefly Aviation (NASDAQ: FLY), a space stock that arrived recently to the market, was plummeting over the past few trading sessions. According to data compiled by S&P Global Market Intelligence its
Should You Buy Dogecoin Right Now?
Cryptocurrencies are always roller-coaster investments, but one that's taken dedicated investors to lofty peaks and -- at times almost as quickly -- punishing lows is Dogecoin (CRYPTO: DOGE).
The
Why CytomX Therapeutics Stock Was Skyrocketing This Week
It isn't difficult for a modestly priced stock to leap in value on a positive news item. That's the dynamic behind the monster rise these past few days of clinical-stage biotech CytomX Therapeutics
Should You Buy ARK 21Shares Bitcoin ETF (ARKB) While It's Under $40?
Cryptocurrency headlines can be tiresome. Who cares if Bitcoin (CRYPTO: BTC) is worth $100,000 or $120,000 per coin, right? Both figures are enough to cover four years of college tuition, or buy a
A Healthcare Debate: Progyny vs. Hims & Hers
In this podcast, Motley Fool analysts Alicia Alfiere, Sanmeet Deo, and Tim Beyers discuss:
To catch full episodes of all The Motley Fool's free podcasts, check out our podcast center. When you're
Why Upstart Holdings Stock Was Trading Down This Week
A researcher reported that there has been a notable rise in short interest with loan marketplace Upstart (NASDAQ: UPST). Since that nugget of information hit the market on Tuesday, the company's
Is D-Wave Quantum Stock Still a Buy?
Quantum computing stocks have become Wall Street's favorite speculation, and D-Wave Quantum (NYSE: QBTS) epitomizes the subsector's promise and peril. The stock has rocketed 213% year to date
Coca-Cola Stock Sell-Off: Should You Buy the Dip?
Coca-Cola (NYSE: KO), which has a roughly 3% dividend yield on its stock, is a company that just about everyone on planet Earth knows. That's a statement to how well run a business it is, which is
MercadoLibre Is the Amazon of Latin America ... or Is It?
When investors talk about MercadoLibre (NASDAQ: MELI), the phrase that comes up almost automatically is "the Amazon (NASDAQ: AMZN) of Latin America." The comparison isn't wrong. MercadoLibre runs
Is There a Future for XRP?
After spending years below $1, XRP (CRYPTO: XRP) has skyrocketed over the last year, gaining 385% (as of Sept. 23). That's far better than Bitcoin, Ethereum, and every other top 10 cryptocurrency.
Could This Single Dividend King Make Your Portfolio Worth $1 Million in 20 Years?
Johnson & Johnson (NYSE: JNJ) is a longtime healthcare leader with numerous positive qualities. These include its 62 consecutive years of dividend increases, which surpass the 50 required to be


